3Korba BE. In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral Res, 1996, 29: 49-64.
4Schalm SW, Heathcote J, Cianclara J, et al. Lamivudlne and alpha interferon combination treatment of patients with chronichepatitis B infection: a randomised trial. Gut, 2000, 46: 562-568.
5Schiff E, Karayalcin S, Grimm I, et al. A placebo-controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon therapy.Hepatology, 1998, 28:388a.
6Mutimer D, Naoumov N, Honkoop P, et al. Combination alphainterferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study. J Hepatol,1998,28:923-929.
7Marinos G, Naoumov NV, Williams R. Impact of complete inhibition of viral replication on the cellular immune response inchronic hepatitis B virus infection. Hepatology, 1996, 24:991-995.
8Leung NWY, Lai CL, Chang TT, et al. Three year lamivudene therapy in chronic HB.J Hepatol, 1999,30 Suppl, 1:59.
9Cotonat T, Quiroga JA, Lopez-Alcorocho JM, et al. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody positive patients.Hepatology, 2000, 31:502-506.
10Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol, 1993,4:273-283.
